Showing 941-950 of 1718 results for "".
- The Good, the Bad and the Ugly of Alternative Medicinehttps://practicalneurology.com/columns/practice-management/the-good-the-bad-and-the-ugly-of-alternative-medicine/31299/Alternative Medicine in Neurology: Navigating Patient Use and Clinical ImplicationsThe June 2006 issue of *Practical Neurology* addresses the rising prominence of alternative medicine within the neurological patient population, underscored by the bestselling yet controversial book by Kevin Trudeau.
- Searching for the Connections Between PFO, Stroke and Migrainehttps://practicalneurology.com/diseases-diagnoses/stroke/pn0406-pfo-pdf/31321/Patent Foramen Ovale: Implications for Stroke and Migraine ManagementRecent advancements in neurology have intensified the focus on patent foramen ovale (PFO), a heart defect present in approximately 40 million Americans. Although many individuals with PFO remain asymptomatic, emerging research sugg
- Intervention Can't Be Justified Without More Precise Patient Selectionhttps://practicalneurology.com/columns/practice-management/intervention-cant-be-justified-without-more-precise-patient-selection/31408/Carotid stenosis management remains a debated topic in neurology, particularly concerning asymptomatic carotid stenosis (ACS). The number needed to treat (NNT), as introduced by Laupacis et al., serves as a crucial metric in determining the effectiveness and cost-efficiency of interventions. For pat
- Vascular Clinichttps://practicalneurology.com/columns/practice-management/vascular-clinic/31422/Advancements in stroke risk assessment are increasingly incorporating novel biomarkers to enhance the prediction beyond traditional factors such as hypertension, diabetes, and hyperlipidemia. This evolution aims to improve long-term stroke risk stratification for patients, offering more precise tool
- Epilepsy Essentialshttps://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN1108Epilepsy-pdf/30972/New Insights into Seizure Recurrence Risk and Epilepsy Management in WomenIn a recent issue of *Practical Neurology* (November 2008), significant findings were presented regarding the recurrence risk of seizures in children following a first afebrile, unprovoked seizure and the specialized managemen
- Bringing Insomnia Treatments Out of the Darkhttps://practicalneurology.com/diseases-diagnoses/sleep/PN0708Insomniafea-pdf/31006/Insomnia in Neurological Practice: Clinical Insights and Management StrategiesInsomnia remains a prevalent and challenging condition within neurology, significantly impacting patients' quality of life. Unlike neurodegenerative disorders such as Alzheimer's or Parkinson's, insomnia presents uniquely
- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31026/Recent Advances and Insights in Neurology PracticeReturning to work post-stroke significantly enhances patients' quality of life, yet numerous barriers impede this transition. A study by the George Institute of International Health in Australia examined 1,429 first-time stroke patients, revealing th
- Rethinking the Safety of Stimulants in ADHDhttps://practicalneurology.com/columns/practice-management/rethinking-the-safety-of-stimulants-in-adhd/31322/Cardiovascular Safety of Stimulants in ADHD Treatment: An Update for CliniciansThe use of stimulants in treating Attention-Deficit/Hyperactivity Disorder (ADHD) has long been a cornerstone in managing this pervasive condition, which affects 5-7% of school-aged children and 3-5% of adults. However, r
- Achieving Freedom From AEDs Without Compromising Controlhttps://practicalneurology.com/columns/practice-management/achieving-freedom-from-aeds-without-compromising-control/31393/Tapering Antiepileptic Drugs: Balancing Seizure Control and Quality of LifeIn the October 2005 issue of *Practical Neurology*, Dr. Christopher Skidmore explores whether epilepsy necessitates lifelong antiepileptic drug (AED) therapy. Highlighting the dual objectives of achieving seizure control whil
- Epilepsy Care: Can We Succeed with Monotherapy?https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/PN0405CvrStry-pdf/31461/Advancements and Challenges in Antiepileptic Drug MonotherapyIn the realm of epilepsy management, achieving seizure freedom remains the primary goal for neurologists and patients alike. Approximately 60-70% of newly diagnosed epilepsy patients achieve control with a single antiepileptic drug (AED),